MCL1 and Miyoshi myopathy: Treatment of MM and DLBCL cell lines with OA resulted in a reduction of MCL-1 in MM cell lines where MCL-1 has a long half-life, but not in cell lines where MCL-1 has a short half-life (Fig. 4A).